Arkolith/Insider Trading/EVMN

EVMN Insider Trading

Evommune, Inc. · full profile →Last filing Jul 8, 2026
Net Selling · 180d
Open-Market Buys (180d)
$146K
2 insiders
Open-Market Sells (180d)
$2.3M
6 insiders
Net Insider Flow
-$2.1M
open market, 180d
Reporting Insiders
8
11 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jul 8, 2026Carver KyleChief Financial OfficerBuy(P)1K$13.26$13K
Jul 7, 2026Kirsch Arthur SDirectorBuy(P)10K$13.30$133K
Jun 22, 2026Drew Janice SuzannChief of Dev. OperationsOption exercise(M)4K$3.84$15K
Jun 22, 2026Drew Janice SuzannChief of Dev. OperationsOption exercise(M)16K$2.99$48K
Jun 22, 2026Drew Janice SuzannChief of Dev. OperationsSell(S)20K$22.63$453K
Jun 22, 2026Drew Janice SuzannChief of Dev. OperationsOption exercise(M)4K—$0
Jun 22, 2026Drew Janice SuzannChief of Dev. OperationsOption exercise(M)16K—$0
Jun 22, 2026Patel Jeegar PravinkumarChief Scientific OfficerOption exercise(M)1K$3.84$6K
Jun 22, 2026Patel Jeegar PravinkumarChief Scientific OfficerSell(S)1K$22.50$33K
Jun 22, 2026Patel Jeegar PravinkumarChief Scientific OfficerOption exercise(M)1K—$0
Jun 22, 2026Pena Luis C.President & CEO, DirectorSell(S)7K$22.71$169K
Jun 2, 2026McGraw Benjamin F IIIDirectorGrant(A)16K—$0
Jun 2, 2026Kirsch Arthur SDirectorGrant(A)16K—$0
Jun 2, 2026Cohen David EDirectorSell(S)5K$20.21$110K
Jun 2, 2026Cohen David EDirectorSell(S)600$21.38$13K
Jun 2, 2026Cohen David EDirectorGrant(A)16K—$0
Jun 1, 2026Patel Jeegar PravinkumarChief Scientific OfficerOption exercise(M)14K$3.84$52K
Jun 1, 2026Patel Jeegar PravinkumarChief Scientific OfficerSell(S)17K$22.74$379K
Jun 1, 2026Patel Jeegar PravinkumarChief Scientific OfficerOption exercise(M)14K—$0
Jun 1, 2026Pena Luis C.President & CEO, DirectorSell(S)17K$22.74$382K
May 28, 2026Moss Gregory S.Chief Business & Legal OfficerOption exercise(M)14K—$0
May 28, 2026Moss Gregory S.Chief Business & Legal OfficerSell(S)14K$22.83$325K
May 28, 2026Moss Gregory S.Chief Business & Legal OfficerOption exercise(M)14K$1.71$24K
May 28, 2026Carver KyleChief Financial OfficerOption exercise(M)15K—$0
May 28, 2026Carver KyleChief Financial OfficerSell(S)18K$22.84$415K
May 28, 2026Carver KyleChief Financial OfficerOption exercise(M)15K$2.99$45K
Apr 16, 2026Patel Jeegar PravinkumarChief Scientific OfficerGrant(A)69K—$0
Apr 16, 2026Moss Gregory S.Chief Business & Legal OfficerGrant(A)115K—$0
Apr 16, 2026Pena Luis C.President & CEO, DirectorGrant(A)291K—$0
Apr 16, 2026Drew Janice SuzannChief of Dev. OperationsGrant(A)74K—$0
Apr 16, 2026Carver KyleChief Financial OfficerGrant(A)99K—$0
Apr 16, 2026Bauer EugeneChief Medical Officer, DirectorGrant(A)51K—$0
Feb 17, 2026LSP 7 Cooperative UADirector, 10% OwnerGrant(A)359K$27.88$10.0M
Feb 17, 2026RA Capital Healthcare Fund LPDirectorGrant(A)36K$27.88$1000K
Feb 17, 2026Verduyn-van Weegen Felice IsabelDirector, 10% OwnerGrant(A)359K$27.88$10.0M
Dec 19, 2025Hopfner Robert LorneDirector, 10% OwnerBuy(P)1K$17.35$17K
Dec 9, 2025Pena Luis C.President & CEO, DirectorTax withholding(F)28K$17.84$502K
Dec 9, 2025Bauer EugeneChief Medical Officer, DirectorTax withholding(F)1K$17.84$26K
Dec 9, 2025Moss Gregory S.Chief Business & Legal OfficerTax withholding(F)14K$17.84$243K
Dec 9, 2025Carver KyleChief Financial OfficerTax withholding(F)13K$17.84$237K
Dec 9, 2025Drew Janice SuzannEVP, OperationsTax withholding(F)5K$17.84$91K
Dec 9, 2025Patel Jeegar PravinkumarChief Scientific OfficerTax withholding(F)8K$17.84$134K
Dec 8, 2025Bauer EugeneChief Medical Officer, DirectorGrant(A)100K—$0
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)7.2M——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)26K——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)7.1M——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)3.6M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)1.6M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)1.4M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)295K——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)2.1M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)1.9M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)7.2M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)2.6M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)3.6M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)7.1M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)2.5M——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)314K——
Nov 7, 2025Pivotal bioVenture Partners Fund I G.P., L.P.Director, 10% OwnerConversion(C)314K——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)2.6M——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)2.5M——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)1.9M——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)2.1M——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)314K——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)314K——
Nov 7, 2025Ra Capital Management, L.P.Director, 10% OwnerConversion(C)1.5M——
Nov 7, 2025Ra Capital Management, L.P.Director, 10% OwnerConversion(C)691K——
Nov 7, 2025Ra Capital Management, L.P.Director, 10% OwnerBuy(P)1.2M$16.00$18.5M
Nov 7, 2025Ra Capital Management, L.P.Director, 10% OwnerBuy(P)93K$16.00$1.5M
Nov 7, 2025Ra Capital Management, L.P.Director, 10% OwnerConversion(C)12.9M——
Nov 7, 2025Ra Capital Management, L.P.Director, 10% OwnerConversion(C)5.9M——
Nov 7, 2025Cohen David EDirectorConversion(C)6K——
Nov 7, 2025Cohen David EDirectorConversion(C)52K——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)3K——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)1.4M——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)295K——
Nov 7, 2025Hopfner Robert LorneDirector, 10% OwnerConversion(C)1.6M——
Nov 7, 2025Pena Luis C.President & CEO, DirectorConversion(C)24K——
Nov 7, 2025Pena Luis C.President & CEO, DirectorConversion(C)206K——
Nov 7, 2025Bauer EugeneChief Medical Officer, DirectorConversion(C)26K——
Nov 7, 2025Bauer EugeneChief Medical Officer, DirectorConversion(C)206K——
Nov 7, 2025Bauer EugeneChief Medical Officer, DirectorConversion(C)13K——
Nov 7, 2025Moss Gregory S.Chief Business & Legal OfficerConversion(C)3K——
Nov 7, 2025Moss Gregory S.Chief Business & Legal OfficerConversion(C)25K——
Nov 7, 2025Carver KyleChief Financial OfficerConversion(C)3K——
Nov 7, 2025Carver KyleChief Financial OfficerConversion(C)25K——
Nov 7, 2025LSP 7 Cooperative UA10% OwnerConversion(C)3.4M——
Nov 7, 2025LSP 7 Cooperative UA10% OwnerBuy(P)1.6M$16.00$25.0M
Nov 7, 2025LSP 7 Cooperative UA10% OwnerConversion(C)5.1M——
Nov 7, 2025LSP 7 Cooperative UA10% OwnerConversion(C)15.5M——
Nov 7, 2025LSP 7 Cooperative UA10% OwnerConversion(C)6.6M——
Nov 7, 2025Drew Janice SuzannEVP, OperationsConversion(C)2K——
Nov 7, 2025Drew Janice SuzannEVP, OperationsConversion(C)13K——
Nov 7, 2025Patel Jeegar PravinkumarChief Scientific OfficerConversion(C)3K——
Nov 7, 2025Patel Jeegar PravinkumarChief Scientific OfficerConversion(C)25K——
Nov 7, 2025Verduyn-van Weegen Felice IsabelDirector, 10% OwnerConversion(C)3.4M——
Nov 7, 2025Verduyn-van Weegen Felice IsabelDirector, 10% OwnerBuy(P)1.6M$16.00$25.0M
Nov 7, 2025Verduyn-van Weegen Felice IsabelDirector, 10% OwnerConversion(C)5.1M——
Nov 7, 2025Verduyn-van Weegen Felice IsabelDirector, 10% OwnerConversion(C)6.6M——
Nov 7, 2025Verduyn-van Weegen Felice IsabelDirector, 10% OwnerConversion(C)15.5M——

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-20. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).